CytomX Therapeutics Inc.
(CTMX)
undefined
undefined%
At close: undefined
1.12
3.70%
After-hours Dec 13, 2024, 07:57 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 101.21M | 53.16M | 69.57M | 100.36M | 57.49M | 59.50M | 71.62M | 15.04M | 7.71M | 5.08M | 888.00K |
Cost of Revenue | - | 5.86M | 5.84M | - | - | - | - | - | - | - | - |
Gross Profit | 101.21M | 47.31M | 63.73M | 100.36M | 57.49M | 59.50M | 71.62M | 15.04M | 7.71M | 5.08M | 888.00K |
Operating Income | -6.48M | -101.33M | -83.78M | -48.60M | -110.89M | -77.87M | -46.26M | -59.59M | -33.20M | -29.77M | -14.96M |
Interest Income | 9.84M | 1.68M | 255.00K | 1.84M | 8.37M | 7.64M | 2.67M | 2.42M | 1.31M | 7.00K | 6.00K |
Pretax Income | 3.32M | -99.32M | -83.61M | -46.80M | -102.67M | -70.30M | -43.61M | -58.92M | -35.36M | -30.30M | -15.13M |
Net Income | -569.00K | -97.30M | -80.65M | -32.88M | -102.24M | -84.60M | -43.10M | -58.90M | -35.37M | -30.31M | -15.14M |
Selling & General & Admin | 30.02M | 42.85M | 39.16M | 36.03M | 36.77M | 33.51M | 25.61M | 19.87M | 12.56M | 6.54M | 4.95M |
Research & Development | 77.68M | 111.65M | 114.19M | 112.94M | 131.62M | 103.87M | 92.28M | 54.76M | 28.36M | 28.30M | 10.89M |
Other Expenses | - | 340.00K | -83.00K | -27.00K | -135.00K | -68.00K | -27.00K | -69.00K | -1.74M | -55.00K | 71.00K |
Operating Expenses | 107.70M | 154.50M | 153.35M | 148.97M | 168.38M | 137.38M | 117.88M | 74.63M | 40.91M | 34.84M | 15.84M |
Interest Expense | - | - | - | - | - | - | - | 1.69M | 1.73M | 487.00K | 254.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 107.70M | 154.50M | 153.35M | 148.97M | 168.38M | 137.38M | 117.88M | 74.63M | 40.91M | 34.84M | 15.84M |
Income Tax | 3.89M | -2.02M | -2.96M | -13.91M | -427.00K | 14.30M | -513.00K | -19.00K | 10.00K | 10.00K | 10.00K |
Shares Outstanding (Basic) | 73.81M | 65.74M | 64.15M | 46.15M | 45.34M | 41.66M | 37.17M | 36.23M | 8.60M | 34.92M | 34.92M |
Shares Outstanding (Diluted) | 73.81M | 65.74M | 64.15M | 46.15M | 45.34M | 41.66M | 37.17M | 36.23M | 8.60M | 34.92M | 34.92M |
EPS (Basic) | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 | -0.43 |
EPS (Diluted) | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 | -0.43 |
EBITDA | -4.31M | -98.89M | -113.34M | -77.97M | -138.88M | -75.99M | -41.97M | -57.85M | -32.43M | -29.03M | -14.22M |
Depreciation & Amortization | 2.17M | 5.86M | 5.84M | 5.46M | 2.60M | 1.88M | 1.65M | 1.73M | 1.21M | 783.00K | 655.00K |